Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The interleukin-12 receptor beta subunit refers to two distinct but related proteins, IL-12 receptor subunit beta 1 (IL12RB1) and IL-12 receptor subunit beta 2 (IL12RB2), which are critical components of the interleukin-12 (IL-12) receptor complex. These type I transmembrane proteins belonging to the hemopoietin receptor superfamily form a high-affinity binding site for IL-12, enabling downstream signaling essential for immune responses. The functional receptor is a heterodimer of IL-12Rβ1 and IL-12Rβ2. IL-12Rβ1 binds to the p40 subunit shared by both IL-12 and IL-23. IL-12Rβ2 is primarily responsible for signal transduction, coupling with the JAK2/STAT4 pathway upon ligand binding. Deficiency or mutations in either subunit can result in severe immunodeficiencies.
Agonist binding leads to activation of JAK2 and STAT4 signaling pathway, enhancing IFNγ production and promoting Th1 differentiation.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Interleukin-12 Receptor Beta Subunit (IL-12Rβ).